SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001206212-04-000104
Filing Date
2004-05-13
Accepted
2004-05-13 14:11:00
Documents
10
Period of Report
2004-05-13

Document Format Files

Seq Description Document Type Size
1 FORM 40-F m12968ore40vf.txt 40-F 14816
2 ANNUAL INFORMATION FORM m12968orexv1.txt EX-1 92431
3 CONSOLIDATED FINANCIAL STATEMENTS m12968orexv2.txt EX-2 107524
4 MANAGEMENT'S DISCUSSION AND ANALYSIS m12968orexv3.txt EX-3 39500
5 CONSENT OF KPMG LLP m12968orexv4.txt EX-4 799
6 CERTIFCATION (DR. FRANCESCA BELLINI) m12968orexv5.txt EX-5 3776
7 CERTIFICATION (CLAUDE MICHAUD) m12968orexv6.txt EX-6 3776
8 CERTIFICATION (DR. FRANCESCA BELLINI) m12968orexv7.txt EX-7 1430
9 CERTIFICATION (CLAUDE MICHAUD) m12968orexv8.txt EX-8 1456
10 CODE OF ETHICS m12968orexv9.txt EX-9 7848
  Complete submission text file 0001206212-04-000104.txt   275889
Mailing Address
Business Address 7220 FREDERICK BUNTING ST STE 100 MONTREAL E6 H4S 2A1 5143374646
NEUROCHEM INC (Filer) CIK: 0001259942 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 40-F | Act: 34 | File No.: 000-50393 | Film No.: 04802341
SIC: 2834 Pharmaceutical Preparations